Phase II study with cisplatin and paclitaxel in combination with weekly high-dose 24 h infusional 5-fluorouracil/leucovorin for first-line treatment of metastatic breast cancer

Anti-Cancer Drugs

Volumn 9, Issue 3, 1998, Pages 203-207

  Klaassen, Ute ^a   Wilke, Hansjochen ^a   Weyhofen, Regina ^a   Harstrick, Andreas ^a   Eberhardt, Wilfried ^a   Müller, Christian ^a   Korn, Michael ^a   Hanske, Michael ^a   Diergarten, Klaus ^a   Seeber, Siegfried ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

5 Fluorouracil; Cisplatin; Leucovorin; Metastatic breast cancer; Paclitaxel

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; PACLITAXEL;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BREAST CANCER; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERANCE; FATIGUE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MUCOSA INFLAMMATION; MYALGIA; NAUSEA; NEUROPATHY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; VOMITING;

EID: 7144242320     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199803000-00002     Document Type: Article

References (7)

1. Wilke H, Klaassen U, Achterrath W, et al. Phase I/II study with a weekly 24 hour infusion of 5-fluorouracil plus high dose folinic acid (HD-FU/FA) in intensively pretreated patients with metastatic breast cancer. Ann Oncol 1996; 7: 55-8.
2. Klaassen U, Wilke H, Phillippou Pari C, et al. Phase I/II study with paclitaxel in combination with weekly high dose 5-fluorouracil/folinic acid (HD-FU/FA) in the treatment of metastatic breast cancer. Semin Oncol 1995; 22(suppl 14): 7-11.
3. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
4. Sledge J, Loehrer PJ, Roth BJ, Einhorn LH. Cisplatin as firstline therapy for metastatic breast cancer. J Clin Oncol 1988; 6: 1811-4.
5. Vanhoefer U, Harstrick A, Wilke H, et al. Schedule dependent antagonism of paclitaxel and cisplatin in human gastric and ovarian carcinoma cell lines in vitro. Eur J Cancer 1995; 31A: 92-7.
6. Wasserheit C, Frazein, A, Oratz R, et al. Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity. J Clin Oncol 1996; 14: 1993-9.
7. Gelmon K, O'Reilly SE, Tolcher AW, et al. Phase I/II trial of biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancer. J Clin Oncol 1996; 14: 1185-91